Would you like to join our consortium as a Doctoral Candidate (DC)?
All sixteen positions
will be opening soon – follow this website closely for announcements and application details.

DC15 – Evaluating the impact of controlled self-experience with psychedelics in therapist training. A clinical trial.

Doctoral Candidate DC15: Charlotte Schiewe | UB Description For this project, the doctoral candidate will be involved in a clinical trial investigating the impact of controlled personal experiences with psychedelics in physicians and psychotherapists within a therapist training context. The study examines the subjective risks and benefits of personal psychedelic experiences in this professional population, […]

DC16 – Clinical development of psychedelic-assisted therapy: transdiagnostic mechanisms and contextual factors

Doctoral Candidate DC16: Aline Frick | UZH Description Psychedelic therapies (PT) are emerging as a promising treatment paradigm across a range of mental health conditions. While early clinical studies demonstrate encouraging efficacy, there remains a need to better understand transdiagnostic mechanisms of therapeutic change and to systematically investigate contextual factors such as set and setting, […]

DC12 – Analysing the obstacles and opportunities of different regulatory pathways to patient access for psychedelic therapies

Doctoral Candidate DC12: Shar Rao | UCPH Description The development of psychedelic therapies in Europe must operate within the established regulatory framework for medicinal products, with centralised marketing authorisation via the European Medicines Agency as the primary route. However, existing regulatory structures were not designed for treatments that combine psychoactive compounds with structured psychotherapeutic interventions, […]

DC14 – Harmonising Ethical Regulation of Psychedelic Therapy with Broader Medical Practices

Doctoral Candidate DC14: Julia Etkin | Charité Description In addition to questions on clinical efficacy and safety of psychedelic therapy, ethical concerns have been raised both in clinical trials and (limited) pre-approval access programs. Ethical aspects will be crucial in the further research and implementation of psychedelic therapy. The objective of this project is to […]

DC10 – Methodological challenges in clinical psychedelic research

Doctoral Candidate DC10: Lukas Heinrich | ULEI Description This DC project addresses key methodological challenges in clinical and experimental psychedelic research, including expectancy and placebo effects, the breaking-blind problem, and limited mechanistic insight. The project aims to empirically evaluate methodological solutions using controlled laboratory studies and complementary naturalistic designs in healthy volunteers. The doctoral candidate […]

DC11 – Health economics of psychedelic therapy

Doctoral Candidate DC11: Cara Tomnay | UU Description This doctoral project focuses on generating robust, policy-relevant evidence on the economic value of psychedelic therapy (PT) across different mental health conditions. While clinical evidence on PT is rapidly expanding, systematic economic evidence remains scarce, limiting informed decision-making regarding its implementation and reimbursement. This project will address […]

DC7 – The role of music and psychotherapeutic support in psychedelic therapy

Doctoral Candidate DC7: Maria Carla Lacidogna | UCPH Description This DC project investigates the role of music and therapist behaviours in psychedelic treatments (PT). The doctoral candidate will contribute to analyses of a music-based preparatory intervention administered prior to psilocybin dosing, as well as the effects of a novel music program played during psilocybin sessions. […]

DC8 – Set and Setting in Psychedelic Therapy: An Anthropological and Clinical Perspective

Doctoral Candidate DC8: Cyprien Basso | INSERM Description Psychedelic therapies have shown promising results in the treatment of mental health conditions, yet growing evidence suggests that their effects cannot be understood solely through pharmacology. Extra-pharmacological factors – often referred to as set and setting – play a crucial role in shaping both therapeutic outcomes and […]

DC9 – Psychotherapy process and psychological intervention techniques in psychedelic therapy: safety and efficacy

Doctoral Candidate DC9: Claudio Daza | CF Description Psychedelic therapies have re-emerged as a promising treatment for several neuropsychiatric disorders, but wide variation in practice leaves open questions about the role of psychotherapy and optimal treatment procedures. This project aims to address concerns regarding the delivery of psychotherapy in psychedelic treatments that may hinder regulatory […]